Foundation Medicine and Its Collaborators Announce Acceptance of 21 Abstracts at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
New studies demonstrate advancements in cancer monitoring, expanded liquid biopsy capabilities, and the validity and utility of complex genomic biomarker detection Oral presentation on a landscape study of tumor mutational burden (TMB) in over 8,000 patients across 24 cancer types using FoundationOne®CDx Multiple abstracts defining the clinical application and demonstrating…